Table 3.

Six-month diabetes treatment outcome in Syrian patients, Shatila primary care clinic, Beirut, Lebanon, 2016–2017

	Baseline HbA1C	Six month HbA1C	p-valuea
HbA1C % - [mean (SD); min-max]
Type-1 DM (n = 20)	9.3 (1.8); 6.0–12.6	8.4 (1.4); 6.7–12.3	0.022
Type-2 DM (n = 23)	9.4 (2.5); 5.8–14.4	8.1 (1.8); 5.7–12.7	0.001
DM and HTN (n = 22)	9.0 (2.0); 5.7–12.9	7.7 (1.6); 5.5–11.8	0.003
HbA1C < 8% - [n (%)]
Type-1 DM (n = 20)	4 (20)	11 (55)	0.016
Type-2 DM (n = 23)	8 (35)	15 (65)	0.016
DM and HTN (n = 22)	7 (32)	14 (64)	0.039

DM diabetes mellitus, HTN hypertension, SD standard deviation

^ap-value <0.05 is statistically significant; Wilcoxon signed rank tests for mean and McNemar tests for proportions